TAKE Solutions announces global release of PharmaReady 5.0

Share Article

Major release packed with new capabilities, enhanced usability, and improved scalability

Clinical, Regulatory, Drug Safety, Supply Chain Collaboration & Enterprise Mobility Solutions

TAKE Solutions

We continuously strive to add value and bring significant and relevant global regulatory standards to our life sciences customer base by acting as a key liaison and a thought-leader in this space.

TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in the Life Sciences and Supply Chain Management domains, today announced the availability of PharmaReadyTM 5.0, a web-based regulatory compliance solution suite for Life Science organizations to ensure faster approvals for their new products. The latest version introduces new document management features, and delivers technology framework upgrades to enhance scalability, response time, and ease-of-use.

PharmaReady 5.0 supports submissions to Swissmedic (in addition to US FDA, Health Canada and EMEA). It comes with an improved dashboard for easier navigation and management of documents from a centralized location, provides more visibility and control of e-document/e-submission processes, and introduces new functionalities including drag and drop for quicker document uploads. In addition, PharmaReady 5.0 includes an enhanced, highly scalable technology framework allowing the suite to run seamlessly on any Microsoft platform.

Speaking on the occasion, Ram Yeleswarapu, President and CEO, TAKE Solutions, said, “TAKE Solutions has understood the pulse of the life sciences market and has worked persistently towards achieving the goal of better value to our customers. Having used both our IT expertise, as well as our domain knowledge, we are proud to release the upgraded version PharmaReady 5.0” He added, “PharmaReady is a stable and growing product line that has been consistently delivering value to our customers across the globe.”

“TAKE is committed to diligently listening to our customers as well as regulators, partners, and competitors,” stated Mike Lewis, Vice President – Life Sciences, TAKE Solutions. “This release is a key milestone marking our continuous efforts to add value and bring significant and relevant global regulatory standards to our life sciences customer base by acting as a key liaison, thought-leader, and solution provider in this space.”

The PharmaReady solution suite is designed specifically for management of SOPs, work instructions, training records, document and submission publishing in the eCTD and other formats, as well as to manage other electronic documents. PharmaReady is in full compliance with global regulatory requirements and was designed to be an easy to use, easy to deploy and affordable solution.

PharmaReady has a record of 100% submission acceptance by regulatory authorities, and this is attributed to four key factors: comprehensive solution that meets the latest requirements, out-of-the-box implementation with minimum start-up time, compliance enabled and a top-notch support team.

Pharmaready has a no. of global customers including Pharmaceutical, Medical device Companies and CROs. A majority of regulatory submissions by Indian Pharma manufacturers are done using Pharmaready products or related services from TAKE.

To learn more about PharmaReady please visit http://www.PharmaReady.com

About TAKE Solutions
TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.

TAKE has been recognized as a leader by IDC’s MarketScape Worldwide Life Sciences R&D IT Outsourcing for 2011.TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit http://www.takesolutions.com.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Shalini Daga
TAKE Solutions
Email >
Visit website